Altered RPE matrix in Sorsby Fundus Dystrophy leads to metabolic dysfunction
Altered RPE matrix in Sorsby Fundus Dystrophy leads to metabolic dysfunction
批准号:
10696149
负责人:
ALLISON Brooke GRENELL
金额:
$4.03万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-10 至 2024-09-09
关键词:
AddressAdultAge related macular degenerationAnimalsBlindnessBruch&aposs basal membrane structureCell Culture TechniquesCellsCessation of lifeCitric Acid CycleClinicalCoculture TechniquesCollagenComplete BlindnessCouplingDataDepositionDevelopmentDiseaseDrusenEnergy MetabolismEnvironmental Risk FactorEnzymesExtracellular MatrixExtracellular ProteinFatty AcidsFunctional disorderGenesGeneticGlucosamineGlucoseHumanHyaluronanHypoxiaImpairmentIn VitroIsotope LabelingIsotopesLaboratoriesLifeLinkLipidsMacular degenerationMass FragmentographyMediatingMetabolicMetabolic dysfunctionMetabolismMetalloproteasesModelingMolecularMusMutationNeural RetinaNutrientNutrient availabilityPathogenesisPathogenicityPathologicPathologyPathway interactionsPhenotypePhotoreceptorsPhysiologicalPlayProcessProductionProlinePropertyProteinsProteomicsReportingRetinaRetinal DegenerationRetinal DystrophyRoleSignal TransductionSorsby&aposs fundus dystrophyStable Isotope LabelingStarvationStructure of retinal pigment epitheliumSystemTIMP3 geneTestingTherapeuticTissuesTracerVariantVisionaerobic glycolysisautosomecancer celldisease-causing mutationeffective therapyextracellulargeographic atrophyin vivoinhibitormetabolic abnormality assessmentmetabolic phenotypemetabolomicsmouse modelmutantnovel therapeuticsnutrient deprivationphotoreceptor degenerationprophylacticstable isotopeuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Age-related macular degeneration (AMD), is the leading cause of blindness in adults over 50 with no effective
treatments available. AMD is caused by multiple genetic and environmental factors making it difficult to replicate
and study in the laboratory. In contrast, Sorby’s Fundus Dystrophy (SFD) is a rare monogenetic disease caused
by mutations in Tissue inhibitor of metalloproteinase 3 (TIMP3) that has significant phenotypic similarities to
AMD. Using animal and cell culture models of SFD, I hope to understand the underlying pathogenic and
molecular mechanisms of RPE/retinal degeneration in SFD and possibly AMD. The retina has a uniquely high
metabolic demand and all nutrients needed to power the retina must be transported across or generated by RPE.
Furthermore, proper RPE metabolism is required for the retina to receive adequate nutrients. Retina utilize
aerobic glycolysis to generate ATP and therefore primarily utilize glucose as their energy substrate. Based on
preliminary data from the Anand-Apte laboratory, I hypothesize that aberrant energy metabolism in the RPE
results in nutrient deprivation in the retina and is a significant contributor to SFD pathology. To address this
hypothesis, I propose 2 specific aims; (i) to determine if SFD RPE cells are deficient in their ability to
produce and/or transport essential metabolites to the retina. Using metabolomics and stable isotopic tracing
within SFD mouse and human ARPE19 cell culture models. I will use gas chromatography mass spectrometry
(GC/MS) to quantify nutrient transport across RPE in vivo and in vitro. The link between TIMP3 mutations and
metabolism perturbations are unclear especially considering that TIMP3 has extracellular localization while
metabolism is an intracellular process. (ii) to investigate if extracellular matrix changes and HA
overproduction are responsible for altered energy metabolism in SFD RPE. Recently, the Anand-Apte
laboratory has reported that SFD RPE expressing mutant TIMP3 S179C produce excess hyaluronan (HA), a
glucosamine that is highly abundant in the extracellular matrix (ECM). I hypothesize that HA overproduction in
SFD RPE cells is responsible for the metabolic phenotype we have observed. Since HA is synthesized from
glycolytic intermediates, HA could impact energy metabolism through multiple mechanisms. Understanding the
details of macular degeneration is the first step towards discovering effective prophylactics and will aid in the
development of new therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Altered RPE matrix in Sorsby Fundus Dystrophy leads to metabolic dysfunction
-
批准号:10315337
-
项目类别:
-
资助金额:$3.87万
-
财政年份:2021
-
负责人:ALLISON Brooke GRENELL
-
依托单位:
海外基金